Showing results (351-360 of 411) with videos related to
Sort By:
Pageof 42
Nature|August 24, 2022
RASA2 ablation in T cells boosts antigen sensitivity and long-term functionJulia Carnevale, Eric Shifrut, Nupura Kale, et al.Scientific Reports|July 15, 2018
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAnessHarriett Holme, Aditi Gulati, Rachel Brough, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2020
Autoantibody Landscape in Patients with Advanced Prostate CancerWilliam S Chen, Winston A Haynes, Rebecca Waitz, et al.Scientific Reports|August 23, 2018
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAnessHarriett Holme, Aditi Gulati, Rachel Brough, et al.The Journal of Pathology|February 25, 2012
A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancersRachael Natrajan, Alan Mackay, Maryou B Lambros, et al.Elife|November 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, et al.Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.Nature Genetics|August 9, 2011
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Clare Turnbull, Emma Ramsay, et al.Journal of the National Cancer Institute|August 14, 2020
Common Susceptibility Loci for Male Breast CancerSarah Maguire, Eleni Perraki, Katarzyna Tomczyk, et al.Cancer Discovery|December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate CancerLisa N Chesner, Fanny Polesso, Julie N Graff, et al.Pageof 42